ClinicalTrials.Veeva

Menu
F

Fraser Eye Care Center | Fraser, MI

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

VRDN-003
VRDN-001
AGN-193408
Lyrica
Ripasudil
K-321

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 9 total trials

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants with Thyroid Eye Disease (TED) (STRIVE)

The investigational drug, VRDN-001, is a monoclonal antibody that inhibits the activity of a cell surface receptor called insulin-like growth factor-...

Active, not recruiting
Thyroid Eye Disease
Drug: VRDN-001 10 mg/kg
Drug: VRDN-001 3 mg/kg

This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the...

Enrolling
Open-angle Glaucoma
Ocular Hypertension
Other: Sham Administration
Drug: AGN-193408 SR

This is a clinical trial assessing the efficacy, safety, and tolerability of an investigational drug, VRDN-003, in participants with active Thyroid E...

Enrolling
Thyroid Eye Disease
Drug: VRDN-003
Drug: Placebo

This is a clinical trial assessing the efficacy, safety, and tolerability of an investigational drug, VRDN-003, in participants with chronic Thyroid...

Enrolling
Thyroid Eye Disease
Drug: Placebo
Drug: VRDN-003

The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24...

Enrolling
Primary Open Angle Glaucoma
Device: Hydrus Microstent
Device: Monofocal IOL

Trial sponsors

Alcon logo
V
AbbVie logo
Kowa logo
Viatris logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems